Vertex executive granted 8,251-share stock award

Vertex Pharmaceuticals executive Amit Sachdev reported an acquisition of 8,251 shares of common stock on 2026-07-21 through a restricted stock unit award that vests on 03/31/2030.

Rhea-AI Filing Summary

Vertex Pharmaceuticals executive Amit Sachdev reported an acquisition of 8,251 shares of common stock on 2026-07-21 through a restricted stock unit award that vests on 03/31/2030. Following this award, he holds 66,512 shares directly, plus 882 shares indirectly via a 401(k) and 6,637 shares held in trust.

Insider Trade Summary

Grant/Award: 8,251 shares

Grant/Award 3 txns

Insider Sachdev Amit

Role EVP Chief Patient & Ext Af Off

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	8,251	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 66,512 shares (Direct); Common Stock — 882 shares (Indirect, 401(k)); Common Stock — 6,637 shares (Indirect, Held in Trust)

Footnotes (1)

1. F1. Restricted stock unit award that vests on 03/31/2030.

Key Figures

Restricted stock unit award: 8,251 shares Award vesting date: 03/31/2030 Direct holdings after award: 66,512 shares +3 more

6 metrics

Restricted stock unit award 8,251 shares Grant of common stock reported on 2026-07-21

Award vesting date 03/31/2030 Vesting date for restricted stock unit award

Direct holdings after award 66,512 shares Common stock held directly following reported transaction

401(k) indirect holdings 882 shares Common stock held indirectly via 401(k)

Trust indirect holdings 6,637 shares Common stock held indirectly, noted as Held in Trust

Reported award price $0.00 per share Price per share for the 8,251-share award

Key Terms

Restricted stock unit, 401(k), Held in Trust, Grant, award, or other acquisition

4 terms

Restricted stock unit financial

"Restricted stock unit award that vests on 03/31/2030."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

401(k) financial

"nature_of_ownership: "401(k)" for indirect common stock holding"

A 401(k) is a type of retirement savings plan offered by employers that allows workers to set aside a portion of their paycheck before taxes are taken out. The money saved in a 401(k) can grow over time through investments, helping individuals build funds for their future retirement. It matters to investors because it provides a tax-advantaged way to save and invest for long-term financial security.

Held in Trust financial

"nature_of_ownership: "Held in Trust" for indirect common stock"

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vertex (VRTX) executive Amit Sachdev report on this Form 4?

Amit Sachdev reported a grant of 8,251 shares of Vertex common stock on 2026-07-21 via a restricted stock unit award that will vest on 03/31/2030, increasing his reported direct holdings.

How many Vertex (VRTX) shares did Amit Sachdev receive and at what cost?

He received 8,251 shares of Vertex common stock through an award with a reported price of $0.00 per share. This reflects an equity compensation grant rather than an open-market purchase.

When do Amit Sachdev’s new Vertex (VRTX) restricted stock units vest?

The restricted stock unit award reported by Amit Sachdev is scheduled to vest on 03/31/2030. Vesting means the 8,251 underlying shares become deliverable to him if applicable conditions are satisfied.

What are Amit Sachdev’s total direct Vertex (VRTX) holdings after this award?

After the reported award, Amit Sachdev’s direct holdings total 66,512 shares of Vertex common stock. This figure comes from the Form 4’s “shares following transaction” column for his direct ownership.

Does Amit Sachdev have indirect holdings of Vertex (VRTX) stock?

Yes. The filing shows 882 shares held indirectly through a 401(k) plan and 6,637 shares held in trust, in addition to his directly held Vertex common stock.

Was Amit Sachdev’s Vertex (VRTX) Form 4 transaction a sale or a grant?

The Form 4 reports a grant/award acquisition of 8,251 shares, coded as an “A” transaction for a restricted stock unit award, with no reported share sales in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/23/2026 - 04:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachdev Amit

(Last) (First) (Middle)

C/O VERTEX PHARMACEUTICALS INCORPORATED

50 NORTHERN AVENUE

(Street)

BOSTON MASSACHUSETTS 02210

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERTEX PHARMACEUTICALS INC / MA [ VRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP Chief Patient & Ext Af Off

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/21/2026		A		8,251(1)	A	$0	66,512	D
Common Stock								882	I	401(k)
Common Stock								6,637	I	Held in Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock unit award that vests on 03/31/2030.

Remarks:

	/s/ Christiana Stevenson, Attorney-in-Fact	07/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)